TRDV3 and neoplasm: Despite the low patient numbers and high heterogeneity regarding tumour types and biopsy locations of this cohort, we confirmed increased TRDV1 and TRDV3 expression in B2MMUT tumours pan-cancer (two-sided linear regression, P = 0.017, adjusted for tumour type and biopsy site; Fig. 1g, Extended Data Fig. 1g and Methods).